Rapid Micro Biosystems (RPID) Total Non-Current Liabilities (2020 - 2026)

Rapid Micro Biosystems has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $41.8 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $41.8 million, up 113.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.8 million (up 113.11% YoY), and the FY2025 annual result was $41.2 million, up 80.78% from the prior year.
• Total Non-Current Liabilities came in at $41.8 million for Q1 2026 at Rapid Micro Biosystems, up from $41.2 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $41.8 million in Q1 2026 to a low of $19.6 million in Q1 2025.
• The 5-year median for Total Non-Current Liabilities is $22.2 million (2024), against an average of $25.4 million.
• Across the five-year window, Total Non-Current Liabilities plunged 83.58% in 2022 and soared 113.11% in 2026, its largest moves.
• Rapid Micro Biosystems' Total Non-Current Liabilities stood at $26.3 million in 2022, then decreased by 4.01% to $25.2 million in 2023, then decreased by 9.46% to $22.8 million in 2024, then surged by 80.78% to $41.2 million in 2025, then advanced by 1.45% to $41.8 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $41.8 million (Q1 2026), $41.2 million (Q4 2025), and $39.7 million (Q3 2025), per Business Quant data.